MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
1.860
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
MDxHealth Revenue
MDxHealth had revenue of $23.32M in the quarter ending September 30, 2024, with 20.50% growth. This brings the company's revenue in the last twelve months to $84.71M, up 33.01% year-over-year. In the year 2023, MDxHealth had annual revenue of $70.19M with 89.43% growth.
Revenue (ttm)
$84.71M
Revenue Growth
+33.01%
P/S Ratio
0.60
Revenue / Employee
$282,360
Employees
300
Market Cap
87.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
Dec 31, 2019 | 11.79M | -16.61M | -58.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
MDXH News
- 5 weeks ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - GlobeNewsWire
- 2 months ago - MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics - Seeking Alpha
- 3 months ago - MDxHealth to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 - GlobeNewsWire
- 5 months ago - MDxHealth Announces Pricing of Offering of Ordinary Shares - GlobeNewsWire
- 5 months ago - MDxHealth Announces Launch of Offering of Ordinary Shares - GlobeNewsWire
- 6 months ago - MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript - Seeking Alpha